Janssen, Alphapharm lay down swords in long-running battle over HIV drug patent
Davies Collison Cave 2019-05-06 12:03 pmBy Cat Fredenburgh | Melbourne
Please login to bookmark Close

Drug maker Janssen will drop its long-running patent lawsuit against Alphapharm after the generic drug maker agreed to refrain from making products that allegedly infringe Janssen’s patents for its HIV drug Prezista.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?

For information on rights and reprints, contact subscriptions@lawyerly.com.au